why choose us

First received: August 08, 2023

Clinical Trial: Hyaluronidase Via LADD Scleroderma-induced Microstomia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Microstomia

Study Type: INTERVENTIONAL


Official Title: Hyaluronidase Via Laser-Assisted Drug Delivery for the Treatment of Scleroderma-induced Microstomia

Brief Summary: Two treatment methods, ablative CO2 laser and intradermal hyaluronidase, will be combined to maximize the beneficial potential of each.Laser-assisted drug delivery (LADD) has been shown to be effective for the administration of medications in diverse skin diseases but not previously reported for the treatment of scleroderma-induced microstomia.By using this laser technique, the investigator can reduce the pain of typical hyaluronidase injections and reap the therapeutic benefit of the laser treatment itself.The…

Read more